Market Announcements 2020
NOVEMBER 2020
19 November – Chairman’s Address and CEO Presentation to 2020 AGM
9 November – $7.3M Capital Raising
5 November – Investor Presentation
OCTOBER 2020
19 October- Notice of Annual General Meeting – Proxy Form
6 October- First Patent Granted for Deoxymab Nanoparticles
SEPTEMBER 2020
28 September- Patrys Adds Full Human Antibody to Deoxymab Portfolio
AUGUST 2020
27 August – Business Review – 30 June 2020
3 August – Entitlement Offer Results and Shortfall Notification
JULY 2020
17 July – Entitlement Offer Website Information
13 July – Research Alliance Between Patrys and Olivia Newton-John Cancer Research Institute
JUNE 2020
22 June – $4.29 Million Fully Underwritten Rights Issue
18 June – Investor Presentation
MAY 2020
18 May – New Research Grants Fund PAT-DX1 and PAT-DX1-NP Targeting Brain Tumors
11 May – New Appointment to Scientific Advisory Board
MARCH 2020
16 March – PAT-DX1 Novel Mechanism for Crossing the Blood Brain Barrier Confirmed
2 March – PAT-DX1-NP Crosses Blood Brain Barrier and Targets Tumours
JANUARY 2020
20 January – PAT-DX1 to be Showcased at International Conference
